Julphar Marks Entry into New Sector at First Mens Health Congress
Julphar (Gulf Pharmaceutical Industries), the largest generic pharmaceutical manufacturer in the MENA region, noted its access right into the guys's health sector with the launch of a new erectile dysfunction product, Dandasha (Tadalafil 20 mg), at the very first Men's Health Congress.
Julphar participated as platinum enroller of the occasion, a leading platform committed to resolving men's health issues. It was arranged under the patronage of His Highness Sheikh Hamdan Bin Rashid Al Maktoum, Deputy Ruler of Dubai, UAE Minister of Financing and the President of the Dubai Health Authority and was held at the Mohammed bin Rashid Academic Medical Center, Dubai Health Care City.
The RAK-based pharmaceutical company later on hosted an occasion to showcase Dandasha at the One & Only Royal Mirage Dubai, which was gone to by His Highness Sheikh Faisal Bin Saqr Al Qasimi, Chairman of Julphar, along with more than 300 medical care professionals.
Talking about the launch, Dr Hosam Badr, Marketing Director at Julphar, said: "Erectile dysfunction is a common trouble affecting around 52 per cent of men worldwide. As leaders in MENA healthcare, we wish to raise understanding and stimulate discussions about some of the concerns lots of males deal with each day both in the UAE and in the region.
" At Julphar, we are committed to improving the lifestyle of our patients, while making sure the quality, safety and integrity of our products. Our participation at the Mens Health Congress together with the main launch of Dandasha marks our entry right into the guys's health market and forms part of our total approach of broadening and diversifying our product pipeline in this important area."
Dandasha (Tadalafil 20 mg) is sold in tablet kind and is an inhibitor of phosphodiesterase kind 5 (PDE5), which mediates leisure of vascular smooth muscular tissue in specific locations of the body, promoting and maintaining erection for approximately 36 hours.
